Expanding horizons: Tempus AI’s sequencing and data capabilities in Japan

Discover how our Japan lab, advanced assays, and localized data strategy streamline global trials and accelerate companion diagnostic development in the Japanese market.

Aug 25, 2026
Life Sciences
Webinar
Headshot of Kara WernerKara WernerVP and General Manager, Life Sciences Sequencing, Tempus
Headshot of Tsuyoshi MitsuhashiTsuyoshi MitsuhashiRepresentative Director and President, GenMine Labs Corp.
Headshot of Shijun JoShijun Jo Head of Life Science Solution, SB TEMPUS Corp.
Headshot of Nike BeaubierNike Beaubier, MDSenior Vice President, Life Science Pathology, Tempus

Session highlights

  • Get an inside look at our state-of-the-art Tokyo facility, current assay portfolio, and upcoming diagnostic developments.

  • Learn how we partner with international biopharma companies to optimize global clinical trials, and can accelerate companion diagnostics (CDx) within the Japanese market.

  • Discover our strategic roadmap for data acquisition in Japan and how it fuels precision medicine.

Related content

White square with a folded top-left corner on a dark background.Webinar
Abstract background with subtle wavy lines creating a dynamic pattern in shades of grey.

Closing gaps in early-stage NSCLC with AI-enabled clinical intelligence

2026-10-14
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract background with a glowing blue-white curved line against a dark, textured surface.

Multimodal foundation models in action: Applications across drug development

2026-10-15
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Abstract gradient fading from white and gray to bright blue with soft, rounded edges.

ESMO Congress 2026

Providers
Life Sciences